Who should not take BPC-157?
Documented caution flags for BPC-157 include active malignancy (theoretical) and pregnancy / nursing (no data). This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for BPC-157 is limited.
Documented caution flags for BPC-157
- Active malignancy (theoretical)
- Pregnancy / nursing (no data)
Reported side effects to weigh
- Mild injection-site irritation
- Lightheadedness in first few doses
- Transient appetite changes
References
- Stable gastric pentadecapeptide BPC 157, review of pharmacology — Sikiric P. et al., Curr Pharm Des, 2018
- Pentadecapeptide BPC 157 effects on rat tendon healing — Krivic A. et al., J Orthop Res, 2006
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on BPC-157
Last updated 2026-06-15.